INTRODUCTION
Poorly water-soluble drugs often require high doses in order to reach therapeutic plasma concentrations after oral administration. Improvement in the extent and rate of dissolution is highly desirable for such compounds, as this can lead to an increased and more reproducible oral bioavailability and subsequently to clinically relevant dose reduction and more reliable therapy. Nu merous works have been carried out in order to modify the dissolution kinetics of poorly soluble drugs to imp rove their bioavailability 1 . Experience with solid dispersions over the last 20-30 years indicates that this is a very fruit ful approach to improving the solubility, dissolution rates and consequently the bioavailability of poorly soluble drugs 2 . A number of insoluble drugs has shown to improve their dissolution character when converted to solid dispersion. Solid dispersion is used to produce a homogeneous distribution of a small amount of drug in solid state 3 .
The concept of SDs was introduced in 1961 by Sekiguchi and Obi 4 in which the drug is dispersed in inert water soluble carrier at solid state. Solid dispersion technology is a well known process used to increase the dissolution kinetics and oral absorption of poorly water soluble drugs using water soluble inert carriers 5 . The use of hydrophilic polymers as carriers for the dissolution enhancement of poorly water-soluble drug is increasing 6 . Several water soluble carriers such as mannitol, urea, lactose, citric acid, polyvinyl pyrrolidone (PVP) and polyethylene glycols (PEG) are used as carriers for SDs 7 .
Do mperidone is described chemically as 5-ch loro-1-
The drug is a benzimidazole derivative with a molecu lar weight of 426. According to biopharmaceutical classification system (BCS), do mperidone is classified under class-II (poor solubility and high permeability). It acts as an antiemetic and a prokinetic agent through its effects on the chemoreceptor trigger zone and motor function of the stomach and small intestine. Unlike metoclopramide, it does not cause any adverse neurological symptoms as it has min imal penetratio n through the blood-brain barrier. It thus provides an excellent safety profile for long-term ad min istration orally in the reco mmended doses 9 .
When given as immediate release tablet onset of action is half an hour and the drug effect lasts for 4-7h. The elimination half life is 5-7 hr and protein binding of Do mperidone is 91-93%. Although, Domperidone is a weak base with good solubility in acidic pH but in alkaline pH, its solubility is significantly reduced 10 . It has poor aqueous solubility (0.986mg/ L) and the oral bioavailability of Domperidone has been reported at the range of 13-17%. The poor aqueous solubility may be one possible reason for its low bioavailability. In order to increase the bioavailability of do mperidone, a controlled release dosage form has been prepared to increase the solubility of Do mperidone in the alkaline mediu m 9 .
Present study was designed to study the effect of PEG 4000 and PVP K25 as a water soluble carrier on solubility and dissolution rate of domperidone. Effect of drug to carrier rat ios on the dissolution of domperidone was also studied. Solid Dispersion was prepared by co grinding and kneading method to compare rates of release of drug. The Solid Dispersions seems to possess great potential to significantly enhance the solubility and dissolution rate of domperidone.
MATERIAL AND MET HODS
Do mperidone was received as gift sample fro m Cotec Pharma (Roorkee, India). PEG 4000 was procured fro m Titan Biotech Ltd., Bh iwad i and PVP K25, Lactose, Starch was procured from CDH, New Delhi. Distilled water was used throughout the study and all the other chemicals used were of analytical grade.
PREPARATION OF SOLID DISPERS IONS OF DOMPERIDONE
Solid dispersions were prepared with two carriers i.e. PEG 4000 and PVP K25 by two different methods i.e. cogrinding and kneading method.
Cogrindi ng method:
The cogrinding mixtures of Do mperidone were prepared using PEG 4000 and PVP K25 as carriers in co mbination in various weight ratios in a mortar and pestle and cogrinded for 5 minutes. The dry mass was pulverized by passing through sieve no. 60. The dried mass was stored in dessicator until fu rther use.
Kneading method: A mixture of Do mperidone, PEG 4000 and PVP K25 in different ratios were wetted with water-ethanol (1:1) mixture and kneaded thoroughly for 30 minutes in a glass mortar. The paste formed was dried in an oven at 40°C until dry. Dried powder was scrapped, crushed, pulverized and passed through sieve no 60 and stored in dessicator. The percent yield of domperidone solid dispersions can be determined by using the following exp ression:
Percent yield = (weight of p repared solid dispersion / weight of drug + carriers) x 100
Preparation of Domperi done soli d dis persion tablets
The required quantities of domperidone solid dispersion, lactose (qs), talc (1%) and magnesium stearate (1%) were mixed thoroughly in a dry mortar. The dried mass was passed through mesh no.60 to break the aggregates. The blend was compressed into 100 mg tablets on a rotary tablet punching machine with punch size of using 9 mm round and flat punches by direct compression as per the formula given in Tab le 2.
Evaluati on of Tablets: All the tablets prepared were evaluated for content of active ingredient, hardness, friability, disintegration time, d issolution rate as per official (I.P) methods. Hardness of tablets was tested using Monsanto hardness tester. Friability of the tablets was determined in a Roche friabilator. Disintegration time was determined in a tablet disintegration test machine using 900ml 0.1M HCL as the dissolution media 12 .
Drug Content Es ti mation
Drug content was determined by weighing rando mly selected tablets, pulverizing to a fine powder. The powder equivalent to 10 mg do mperidone was weighed and dissolved in 10 ml of methanol in volumetric flask using magnetic stirrer, the volume was adjusted to 100 ml with 0.1M Hcl and the solution was filtered. An aliquot of 1.0 ml of solution were diluted to 10 ml 0.1M Hcl in separate volumetric flask. The drug content in was determined spectrophotometrically at 284 n m (λ max) 13 . 
Fourier-transform infrared (FTIR) s pectroscopy
Fourier-transform infrared (FT -IR) spectra were recorded using an FT-IR spectrophotometer (Sh imadzu ). The samples (domperidone and its SDs) were previously ground and mixed thoroughly with potassium bro mide, an infrared transparent matrix, at 1:5 (Samp le: KBr) ratio, respectively. The KBr discs were prepared by compressing the powders at a pressure of 5 tons for 5 min in a hydraulic press. The scanning range was 400-4700 cm-1 14 .
Differential scanning calori metry (DSC)
A differential scanning calorimeter (DSC 7, PERKIN-ELM ER) at IIT Delhi was used to obtain the DSC curves representing the rates of heat uptake. About 5 mg of sample was weighed in a standard open aluminu m pan. An empty pan of the same type was used as the reference. Samples were heated fro m 50 to 300 °C at a heating rate of 10 °C/ min wh ile being purged with dry n itrogen. Calibrat ions of temperature and heat flow were performed with indiu m 15 .
Dissolution studies:
Dissolution studies were conducted using USP II paddle type dissolution apparatus by taking an accurately weighed amount of the prepared system equivalent to 10 mg of the drug was added to each jar. The d issolution mediu m used was 900 ml of 0.1N HCl, maintained at 37±0.5 °C at a speed of 50 rp m. The dissolution study was performed for 1 hr. 5 ml sample was withdrawn out at specified intervals of time and filtered. The in itial volu me was maintained by adding 5 ml of fresh dissolution mediu m to maintain a constant volume after each sampling. The removed samples were analy zed spectrophotometrically at 284.0 n m (λmax). Similarly a co mparative in vit ro drug release evaluation was also carried out between the prepared systems F1, F2, F3, S1, S2, S3 and a marketed formulat ion (tablet).
RES ULTS AND DISCUSS ION Percentage Yiel d:
The percent yield of domperidone solid dispersions ranged between 97 to 99%.
Drug content:
Results depicted in Table 3 shows that the drug concentration in solid dispersions ranged between 97.86 and 98.96 %. 
Evaluati on of prepared tablets
Hardness, disintegration time and friability of all formulat ions were found between 4 to 6 kg/cm2, 2.3 to 6.5 min and 0.30 to 0. 47 %. Release profile of all the formulat ion was shown in Figure 1 . It was found that Batch S2 gives desirable fast release action. Moreover, hardness, disintegration time, and friability of S2 tablet were found 4±0.2 kg/c m2 , 2.3min and 0.31 %.
Dissolution Studies
Dissolution profiles of prepared solid dispersion tablets and marketed samples in different med ia were studied is shown in figure 1, 2 (Table 6 ). The enhancement of dissolution of domperidone fro m the drug carrier may be due to several factors such as lack of crystallinity, increased wettability and dispersibility. Incorporation of drug with a hydrophilic carrier system offered an increased wetting and reduction in interfacial tension between hydrophobic drug and dissolution mediu m. The order of efficiencies of products based on percentage drug release after 60 minutes is S2>F2>marketed formulat ion>S1>F1>S3>F3. 
Differential scanning calori metry (DSC)
The DSC curves of pure domperidone and its solid dispersion using PEG 4000 and PVP K 25 co mb ination (S2) are shown in Fig. 7 . The DSC curves of pure domperidone showed one sharp endothermic peak at 251.482°C corresponding to domperidone crystalline nature with enthalpy (ΔH) of 105.605 J/g. On the other hand, the DSC curves of domperidone solid dispersion using PEG 6000 and PVP K 30 combination showed two endothermic peaks, a sharp peak at 59.742°C corresponding to PEG with enthalpy (ΔH) of 70.472 J/g and a broad peak at 212.580°C corresponding to domperidone in solid dispersion with enthalpy (ΔH) of 51.194 J/g. Peak temperature in solid dispersions shifted slightly to lower temperature with respect to the drug alone and there was a decrease in ΔH value of solid dispersion(51.194 J/g ) compared to the pure drug (105.605 J/g). These phenomena could be attributed to the amorphous form of the drug in solid dispersions and indicating absence of crystalline drug. 
Fourier transforms infrared (FTIR) s pectroscopy
Fourier transform infrared spectroscopy was performed on pure domperidone (DMP) and its solid dispersion. Pure DMP spectra showed sharp characteristic peaks at 3360,1720,2818,1677 and1488 cm-1. All the above characteristic peaks appear in the spectra of domperidone solid dispersion at same wave number indicating no modification or interaction between the drug and carrier. 
DISCUSS ION
The enhancement of dissolution of domperidone fro m drug carrier systems can be described to several other factors also. Lack of crystallinity, i.e. amorphization, increased wettability, dispersibility and particle size reduction are considered to be important factors for dissolution rate enhancement. As indicative from dissolution data of cogrinding mixtures, improvement could be attributed to higher wettability and dispersibility. Dry mixing of drug with a hydrophilic carrier results in greater wetting and increases surface available for dissolution by reducing interfacial tension between hydrophobic drug and dissolution media. Furthermo re, kneading results in uniform distribution of drug in the polymer crust in a highly dispersed state. Thus, when such a system comes in contact with an aqueous dissolution mediu m, the hydrophilic carrier dissolves and results in precipitation of the embedded drug into fine particles, which increase the dissolution surface available. Moreover, other factors such as absence of aggregation and/or reagglomerat ion phenomenon during dissolution and particle size reduction could be attributed to a better dissolution profile.
CONCLUS ION
Do mperidone is practically insoluble in water and aqueous flu ids. As such the oral absorption of domperidone is dissolution rate limited. A mong the various approaches to improve the dissolution of poorly soluble drugs, the preparation of solid dispersions has often proven to be very successful; hydrophilic carrier was used in the preparation
